Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Forex

Royal Bank of Canada Ups Stake in Edwards Lifesciences Following Q1 Earnings Beat

Guavy AI Editorial Team
Instruments
CAD
Share

Royal Bank of Canada raised its stake in Edwards Lifesciences by 18.1% in Q1, according to the company's most recent 13F filing with the SEC.

The firm owned approximately 0.42% of Edwards Lifesciences' stock worth $195,956,000 at the end of Q1, after acquiring an additional 375,801 shares during the period.

Edwards Lifesciences reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.04.

More on Forex

Forex just now

Canada's Economy Absorbs Rolling Shocks Without Broad-Based Recession

Forex just now

Fed's Interest Rate Decision Leaves Room for Future Hike

Forex 1m ago

Fed Keeps Rates Unchanged, Leaves September Hike in Limbo

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy